Arrivent BioPharma, Inc. (AVBP)
29.79
-0.49
(-1.62%)
USD |
NASDAQ |
Sep 09, 16:00
29.84
+0.06
(+0.18%)
After-Hours: 20:00
Arrivent BioPharma Market Cap : 1.439B for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 09, 2026 | 1.439B |
| September 08, 2026 | 1.463B |
| September 04, 2026 | 1.495B |
| September 03, 2026 | 1.499B |
| September 02, 2026 | 1.474B |
| September 01, 2026 | 1.457B |
| August 31, 2026 | 1.452B |
| August 28, 2026 | 1.458B |
| August 27, 2026 | 1.498B |
| August 26, 2026 | 1.505B |
| August 25, 2026 | 1.515B |
| August 24, 2026 | 1.366B |
| August 21, 2026 | 1.407B |
| August 20, 2026 | 1.410B |
| August 19, 2026 | 1.451B |
| August 18, 2026 | 1.450B |
| August 17, 2026 | 1.402B |
| August 14, 2026 | 1.426B |
| August 13, 2026 | 1.450B |
| August 12, 2026 | 1.520B |
| August 11, 2026 | 1.517B |
| August 10, 2026 | 1.497B |
| August 07, 2026 | 1.397B |
| August 06, 2026 | 1.405B |
| August 05, 2026 | 1.387B |
| Date | Value |
|---|---|
| August 04, 2026 | 1.427B |
| August 03, 2026 | 1.343B |
| July 31, 2026 | 1.351B |
| July 30, 2026 | 1.389B |
| July 29, 2026 | 1.361B |
| July 28, 2026 | 1.358B |
| July 27, 2026 | 1.367B |
| July 24, 2026 | 1.438B |
| July 23, 2026 | 1.429B |
| July 22, 2026 | 1.379B |
| July 21, 2026 | 1.280B |
| July 20, 2026 | 1.279B |
| July 17, 2026 | 1.504B |
| July 16, 2026 | 1.484B |
| July 15, 2026 | 1.493B |
| July 14, 2026 | 1.474B |
| July 13, 2026 | 1.524B |
| July 10, 2026 | 1.526B |
| July 09, 2026 | 1.526B |
| July 08, 2026 | 1.513B |
| July 07, 2026 | 1.549B |
| July 06, 2026 | 1.563B |
| July 02, 2026 | 1.571B |
| July 01, 2026 | 1.563B |
| June 30, 2026 | 1.574B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Cytokinetics, Inc. | 10.28B |
| Gilead Sciences, Inc. | 180.75B |
| Ionis Pharmaceuticals, Inc. | 9.279B |
| Vertex Pharmaceuticals, Inc. | 132.02B |
| ACADIA Pharmaceuticals, Inc. | 4.765B |
Market Cap Related Metrics
| Price to Book Value | 3.924 |
| Price | 29.79 |
| Earnings Yield | -12.36% |